Clinical Trials Browser

Phase 1 × Terminated × HER2-positive Breast Cancer × Clear all

NCT05511844 2025-07-04

Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors

Phase 1 Terminated

HER2-positive Breast Cancer